Aegros logo

Aegros jobs and careers

Macquarie Park, Australia

About Aegros

At Aegros we believe access to life saving therapeutic plasma drugs is a human right and not a privilege. Our mission is to put the patient first through innovation and we do this thanks to our Australian invented Haemafrac®, Aegros' unique electroseparation process. Our TGA GMP-approved plasma fractionation plant in Macquarie Park, Sydney, manufactures a hyperimmune immunoglobulin product against Covid-19, made from convalescent plasma. Aegros is currently undertaking the final preparations for the submission of a dossier for the registration of this hyperimmune against Covid-19 on the Australian Register of Therapeutic Goods (ARTG) Simultaneously, Aegros is finishing the upgrade of its existing hyperimmune facility at Macquarie Park NSW to be able to process 100,000l of plasma per year.

Founded
2017
Employees
125
Headquarters
Macquarie Park

Leadership

The top of Aegros's org chart, with how many people report into each leader.

RAPhoto of Ranjeet Ajmani

Ranjeet Ajmani

Is Chief Executive Officer For Aegros Asia.

20 reports

JBPhoto of Janet Bowen

Janet Bowen

Executive Director, Chief Quality and Regulatory Officer at Aegros Innovations

7 reports

YPPhoto of Yair Pilpel

Yair Pilpel

Chief Scientific Officer (CSO)

5 reports

SF

Shawn X. Feng

Head Of Finance Operations

1 report

CCPhoto of Christina Chen

Christina Chen

Senior Director Of Process Development

1 report

APPhoto of Amir Pourabed

Amir Pourabed

Head of Special Projects

MSPhoto of Mike Swan

Mike Swan

Chief Marketing Officer

Jobs at Aegros

No open positions right now. Explore more companies on TheJobsMap.